Change history
16 October 2020
Authors would like to correct the first name of author Joanne Wang from Joanne to Joanna.
References
Wentworth JM, Bediaga NG, Giles LC, Ehlers M, Gitelman SE, Geyer S et al (2019) Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables. Diabetologia 62(1):33–40
Wentworth JM, Bediaga NG, Gitelman SE, Evans-Molina C, Gottlieb PA, Colman PG et al (2020) Clinical trial data validate the C-peptide estimate model in type 1 diabetes. Diabetologia 63(4):885–886
Culina S, Lalanne AI, Afonso G, Cerosaletti K, Pinto S, Sebastiani G, et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol. 2018;3(20).
Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H et al (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384–1390
Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC et al (2012) Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 61(8):2066–2073
Acknowledgements
We are grateful to all ImMaDiab participants for their time and effort.
Author information
Authors and Affiliations
Consortia
Contributions
All authors devised the study. JW, JMW and NGB performed data analyses. JMW drafted the manuscript, which all authors edited. John Wentworth is the guarantor of this work and takes full responsibility for the work as a whole, including the study design, access to data, and the decision to submit and publish the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors reports a conflict of interest.
Ethical approval
This study was approved by the Comité de Protection des Personnes Ile de France 1–2.
Informed consent
Informed consent was obtained from all study participants.
Additional information
Managed by Massimo Federici.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ImMaDiab Investigators and their affiliations are listed in the Appendix.
The original version of this article was revised: First name of author Joanne Wang corrected from Joanne to Joanna.
Appendix—Members of the ImMaDiab Study Group
Appendix—Members of the ImMaDiab Study Group
Jean-Claude Carel, Nadia Tubiana-Rufi, Laetitia Martinerie, Amélie Poidvin, Evelyne Jacqz-Aigrain, Laurence Corvez, Véronique Berruer (Robert Debré Hospital, Paris). Jean-François Gautier, Baz Baz, Nassima Haddadi (Saint Louis Hospital, Paris). Fabrizio Andreelli, Chloé Amouyal, Sophie Jaqueminet, Olivier Bourron, Eric Dasque, Agnès Hartemann (Pitié-Salpêtrière Hospital, Paris). Amal Lemoine-Yazigi, Danièle Dubois-Laforgue (Cochin Hospital, Paris). Florence Travert, Marilyne Feron, Patrice Rolland, Valérie Vignali, Michel Marre (Bichat. Hospital, Paris). Philippe Chanson, Claire Briet (Kremlin-Bicêtre Hospital, Paris). Pierre-Jean Guillausseau, Leila Ait-Bachir (Lariboisière Hospital, Paris). Carole Collet, Frédéric Beziaud, Virginie Desforges-Bullet, Gwenaelle Petit-Aubert. (Versailles André Mignot Hospital, Le Chesnay). Sophie Christin-Maitre, Bruno Fève, Camille Vatier, Nathalie Bourcigaux, Céline Lautridou. (Saint Antoine Hospital, Paris). Najiba Lahlou (Laboratory of Hormonology, Cochin Hospital, Paris). Prissile Bakouboula, Caroline Elie, Hélène Morel, Jean-Marc Treluyer (Clinical Research. Unit Paris Centre Descartes, Paris). Marie-Claude Gagnerault, Claire Maillard, Anna Jones (INSERM U1016, Cochin Institute, Paris).
Rights and permissions
About this article
Cite this article
Wang, J., Bediaga, N., Mallone, R. et al. Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes. Acta Diabetol 58, 115–117 (2021). https://doi.org/10.1007/s00592-020-01604-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-020-01604-7